Clinical trial

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

NCT00000831

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Lamivudine Normalized identity: lamivudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Stavudine Normalized identity: stavudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Zidovudine Normalized identity: zidovudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Didanosine Normalized identity: didanosineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE2

Conditions

HIV Infectionsunresolved

Interventions

LamivudineDRUG · verified · RxNorm: lamivudine

StavudineDRUG · verified · RxNorm: stavudine

ZidovudineDRUG · verified · RxNorm: zidovudine

DidanosineDRUG · verified · RxNorm: didanosine

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Mapped research locations

BostonMassachusetts, United States4 ChicagoIllinois, United States3 New YorkNew York, United States2 Los AngelesCalifornia, United States2 St LouisMissouri, United States2 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 AtlantaGeorgia, United States1 MiamiFlorida, United States1 San FranciscoCalifornia, United States1 SeattleWashington, United States1 ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00000831 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.